As of 2025-07-17, the EV/EBITDA ratio of New Horizon Health Ltd (6606.HK) is -69.48. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 6606.HK's latest enterprise value is 5,238.12 mil HKD. 6606.HK's TTM EBITDA according to its financial statements is -75.39 mil HKD. Dividing these 2 quantities gives us the above 6606.HK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 21.9x - 25.2x | 23.8x |
| Forward P/E multiples | 8.0x - 9.7x | 9.1x |
| Fair Price | (1.57) - 0.69 | (0.56) |
| Upside | -111.1% - -95.1% | -104.0% |
| Date | EV/EBITDA |
| 2025-07-16 | -589.97 |
| 2025-07-15 | -589.97 |
| 2025-07-14 | -589.97 |
| 2025-07-11 | -589.97 |
| 2025-07-10 | -589.97 |
| 2025-07-09 | -589.97 |
| 2025-07-08 | -589.97 |
| 2025-07-07 | -589.97 |
| 2025-07-04 | -589.97 |
| 2025-07-03 | -589.97 |
| 2025-07-02 | -589.97 |
| 2025-06-30 | -589.97 |
| 2025-06-27 | -589.97 |
| 2025-06-26 | -589.97 |
| 2025-06-25 | -589.97 |
| 2025-06-24 | -589.97 |
| 2025-06-23 | -589.97 |
| 2025-06-20 | -589.97 |
| 2025-06-19 | -589.97 |
| 2025-06-18 | -589.97 |
| 2025-06-17 | -589.97 |
| 2025-06-16 | -589.97 |
| 2025-06-13 | -589.97 |
| 2025-06-12 | -589.97 |
| 2025-06-11 | -589.97 |
| 2025-06-10 | -589.97 |
| 2025-06-09 | -589.97 |
| 2025-06-06 | -589.97 |
| 2025-06-05 | -589.97 |
| 2025-06-04 | -589.97 |
| 2025-06-03 | -589.97 |
| 2025-06-02 | -589.97 |
| 2025-05-30 | -589.97 |
| 2025-05-29 | -589.97 |
| 2025-05-28 | -589.97 |
| 2025-05-27 | -589.97 |
| 2025-05-26 | -589.97 |
| 2025-05-23 | -589.97 |
| 2025-05-22 | -589.97 |
| 2025-05-21 | -589.97 |
| 2025-05-20 | -589.97 |
| 2025-05-19 | -589.97 |
| 2025-05-16 | -589.97 |
| 2025-05-15 | -589.97 |
| 2025-05-14 | -589.97 |
| 2025-05-13 | -589.97 |
| 2025-05-12 | -589.97 |
| 2025-05-09 | -589.97 |
| 2025-05-08 | -589.97 |
| 2025-05-07 | -589.97 |